Announcements Trials
Browse Landscape

Phase

Phase 2 83Phase 3 14Phase NA 13Phase 1/2 7Phase 1 6Phase 2/3 4Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 4Recruiting 4Not yet recruiting 3Completed 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 33Carcinoma, Hepatocellular 27Neoplasms 19Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 15Leukemia, Myeloid, Acute 15Prostatic Neoplasms 12Lung Neoplasms 12Colonic Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Rectal Neoplasms 10Neoplasm Metastasis 8Leukemia 8Pancreatic Neoplasms 7NSCLC 6Multiple Myeloma 6Liver Neoplasms 6Esophageal Neoplasms 6Glioblastoma 5Small Cell Lung Carcinoma 4Recurrence 4Polycystic Ovary Syndrome 4Nasopharyngeal Carcinoma 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Gestational Trophoblastic Disease 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4

Interventions

Radiotherapy 2Esophagectomy 2Cisplatin 2nimotuzumab 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Fluorouracil 1Drug Therapy 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Esophageal Squamous Cell Carcinoma × Clear all
NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Shanghai Zhongshan Hospital

Phase 2/3 Unknown
90 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

National Taiwan University Hospital

Phase 2/3 Unknown
248 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01402180 2011-07-26

Nimotuzumab

Fudan University

Phase 2/3 Unknown
128 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡